Your browser doesn't support javascript.
loading
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Tang, Monica; O'Connell, Rachel L; Amant, Frederic; Beale, Philip; McNally, Orla; Sjoquist, Katrin M; Grant, Peter; Davis, Alison; Sykes, Peter; Mileshkin, Linda; Moujaber, Tania; Kennedy, Catherine J; deFazio, Anna; Tan, King; Antill, Yoland; Goh, Jeffrey; Bonaventura, Tony; Scurry, James; Friedlander, Michael.
Afiliação
  • Tang M; NHMRC Clinical Trials Centre, The University of Sydney, Levels 4-6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, NSW 2050, Australia. Electronic address: monica.tang@unsw.edu.au.
  • O'Connell RL; NHMRC Clinical Trials Centre, The University of Sydney, Levels 4-6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, NSW 2050, Australia.
  • Amant F; Department of Oncology, University of Leuven, Oude Markt 13, 3000 Leuven, Belgium; Centre for Gynaecologic Oncology, Netherlands Cancer Institute and Amsterdam Medical Centres, Plesmanlaan 121, 1066, CX, Amsterdam, Netherlands.
  • Beale P; Concord Repatriation General Hospital, Hospital Rd, Concord, NSW 2139, Australia.
  • McNally O; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia; Royal Women's Hospital, 20 Flemington Rd, Parkville, VIC 3052, Australia; University of Melbourne, Parkville, VIC 3010, Australia.
  • Sjoquist KM; NHMRC Clinical Trials Centre, The University of Sydney, Levels 4-6 Medical Foundation Building, 92-94 Parramatta Rd, Camperdown, NSW 2050, Australia.
  • Grant P; University of Melbourne, Parkville, VIC 3010, Australia; Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC 3084, Australia.
  • Davis A; The Canberra Hospital, Yamba Dr, Woden, ACT 2606, Australia; Australian National University, Canberra, ACT 0200, Australia.
  • Sykes P; University of Otago Christchurch, Christchurch Women's Hospital, 2 Riccarton Ave, Christchurch Central, Christchurch 8011, New Zealand.
  • Mileshkin L; Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia; Royal Women's Hospital, 20 Flemington Rd, Parkville, VIC 3052, Australia; University of Melbourne, Parkville, VIC 3010, Australia; Mercy Hospital for Women, 163 Studley Rd, Heidelberg, VIC 3084, Australia.
  • Moujaber T; The Westmead Institute for Medical Research, The University of Sydney, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.
  • Kennedy CJ; The Westmead Institute for Medical Research, The University of Sydney, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia; Department of Gynaecological Oncology, Westmead Hospital, Hawkesbury Rd, Westmead, NSW 2145, Australia.
  • deFazio A; The Westmead Institute for Medical Research, The University of Sydney, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia; Department of Gynaecological Oncology, Westmead Hospital, Hawkesbury Rd, Westmead, NSW 2145, Australia.
  • Tan K; NSW Health Pathology, The Institute for Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Darcy Rd, Westmead, NSW 2145, Australia.
  • Antill Y; Frankston Hospital, Hastings Rd, Frankston, VIC 3199, Australia.
  • Goh J; Royal Brisbane and Women's Hospital, Bowen Bridge Rd and Butterfield St, Herston, QLD 4029, Australia; University of Queensland, St Lucia, QLD 4072, Australia.
  • Bonaventura T; Calvary Mater Newcastle, Edith St and Platt St, Waratah, NSW 2298, Australia.
  • Scurry J; Pathology New South Wales, Hunter New England, Lookout Rd, New Lambton Heights, NSW 2305, Australia; Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia.
  • Friedlander M; Prince of Wales Clinical School, UNSW Sydney, NSW 2052, Australia; Royal Hospital for Women, Barker St, Randwick, NSW 2031, Australia.
Gynecol Oncol ; 154(3): 531-538, 2019 09.
Article em En | MEDLINE | ID: mdl-31227223

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores de Estrogênio / Cistadenocarcinoma Seroso / Carcinoma Epitelial do Ovário / Anastrozol Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Receptores de Estrogênio / Cistadenocarcinoma Seroso / Carcinoma Epitelial do Ovário / Anastrozol Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article